3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
6
Head & Neck
1
CNS
1
Conditions
Head and Neck Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
11
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
6
Neoplasms
4
Melanoma
4
Laryngeal Diseases
4
Carcinoma
3
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Neoplasms, Squamous Cell
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Hypopharyngeal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Carcinoma, Anaplastic
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Interventions
selpercatinib
2
pralsetinib
2
repotrectinib
1
pembrolizumab
1
alectinib
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiratory Tract Diseases
×
Pemetrexed
×
Head & Neck
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts